Sex differences in colorectal cancer incidence and survival vary by age and tumor subsite in a nationwide Korean cohort
Year: 2026
Type: article
Study design: Observational Study
Abstract: Colorectal cancer (CRC) is one of the most common malignancies worldwide, and sex differences in its incidence and survival have been consistently reported. However, whether these disparities vary according to age, anatomical subsite, and disease stage remains incompletely understood. We conducted a nationwide retrospective cohort study using linked Korean cancer registry and mortality data. Among 215,830 individuals aged ≥ 20 years diagnosed with CRC during 2012–2020, directly age-standardized incidence rate ratios (IRRs) comparing males with females were estimated, and overall survival was evaluated using multivariable Cox models. The IRR increased from 1.17 (95% confidence interval [CI], 1.14–1.21) at < 50 years to 1.94 (95% CI, 1.92–1.96) at 50–74 years. Male predominance was most pronounced in rectal and left-sided colon cancers, whereas right-sided colon cancer showed modest sex differences. Among individuals aged < 50 years, left-sided colon cancer showed female predominance (IRR, 0.92). Males had poorer overall survival, with the greatest disadvantage at 50–74 years (hazard ratio [HR], 1.34), in localized disease (HR, 1.50), and in rectal cancer (HR, 1.31). These findings indicate age-dependent and anatomically heterogeneous sex differences in CRC incidence and survival and support further investigation of sex- and age-informed prevention, screening, and management strategies.
Source: Scientific Reports
Institutions: Kosin University, National Cancer Center, Seoul National University, Seoul National University Hospital, Seoul National University Bundang Hospital, National Evidenc- based healthcare Collaborating Agency, Korea University Anam Hospital, Chonnam National University Hwasun Hospital, Samsung Medical Center, Sungkyunkwan University, Ewha Womans University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
Funder: National Institutes of Health
OpenAlex ID: W7225995982
